In the previous post, we highlighted
a study from the USDA that examined the health benefits of limonin glucoside
(LG) supplementation, as indicated by circulating levels of blood lipids,
glucose and biomarkers of chronic inflammatory diseases, in human subjects. As
can be seen from the complicated HPLC trace shown above, recovery of pure
limonoid glucosides from natural sources in order to fund these types of human
studies is not a trivial undertaking. Moreover, given the molecular complexity
of most limonoids, chemical synthesis may not necessarily provide a viable supply
chain alternative. In my rough estimation, the USDA study required the sourcing
of about one hundred grams of limonin glucoside containing very low levels of its
corresponding aglycone, limonin. While limonin glucoside is tasteless, limonin
tastes extremely bitter and beverage concentrations of >6 mg/liter render
citrus juice unacceptable to consumers. In fact, the original isolation of LG by
the USDA produced material that was insufficiently pure. Taste tests of the
resulting formulated beverages indicated that they were too bitter for human consumption
due to limonin aglycone contamination. In this post, we will outline and
discuss the optimized citrus extraction process that was eventually developed in
order to support the human LG supplementation study.
Citrus molasses, a thick, viscous
liquid that is dark brown to almost black in color, is a major by-product of
citrus processing. The fresh pulp obtained after pressing the fruit is mixed
with lime (calcium oxide) and pressed to remove moisture. The resulting liquid
is then filtered to remove the larger particles, sterilized by heating and
concentrated to produce molasses. Citrus molasses is often fed to animals or
fermented to produce ethanol, yielding meager profit margins for juice
producers. Interestingly, HPLC and LC/MS analyses (see Figure above, left-hand
panel) have shown that limonoid glucosides are present in significant amounts
in molasses. A preparative scale method for recovery of LGs from citrus
molasses was disclosed in 2002 by Thomas Schoch, Gary Manners and Shin Hasegawa
at the USDA.
A schematic flow diagram of the USDA process is reproduced in the Figure above. To begin, one to two liters of crude
molasses is diluted with distilled water and the resulting solution is
centrifuged. The supernantant thus obtained is then loaded onto a column
containing Dowex 50WX4-100 resin and the outflow of the column is directly
connected to a second column containing SP70 Sepabeads. Ethanol is used to
elute the partially purified mixture from the second column. The Dowex column,
a sulfonic acid cation-exchange resin, is intended to remove colored compounds
present in molasses. The Sepabeads, which are a divinylbenzene copolymer
(basically polystyrene), subsequently absorb and remove hydrophobic components.
The eluent solution from the SP70 column is then adjusted to pH 6.5 with dilute
aqueous sodium hydroxide in order to maintain consistent chemical reactivity
and chromatographic behavior within the partially purified LG mixture.
The LG solution is then loaded onto
a Q-Sepharose column and the column is eluted with an aqueous sodium chloride
gradient. The Q-Sepharose stationary phase is a quaternary ammonium resin,
designed to bind negatively charged compounds. Limonin glucosides are
relatively acidic (pKa~2.8) and are therefore anionic at pH 6.5.
The salt gradient elutes the negatively charged limonoids in order of
decreasing pKa, enabling separation of the LGs from things like
flavonoids, which are phenolic and less acidic. The resulting LG-containing
fractions are then subjected to a second Dowex/SP70 treatment and the solvent is
finally removed by iterative co-evaporation with ethanol to furnish a
golden-brown limonoid powder. The method outlined above can produce about ten
grams of >60% pure limonoid glucoside feedstock per week. Further
re-purification of the powder by recrystallization from warm water yields
semi-pure limonin glucoside, contaminated predominantly with unacceptably high
levels of the corresponding aglycone, limonin. In order to remove the bitter
limonin impurity, an HPLC ‘polishing’ method utilizing food grade solvents
(aqueous ethanol) was developed. Using a 75 x 300 mm C18 column, the method is
capable of processing 20 grams of material per run in less than three hours.
Recovery of the purified limonin glucoside following evaporation of solvent is
nearly perfect (~94%) and the limonin content is consistently reduced to
<0.10% by weight. Estimating conservatively, it looks like about two liters
of molasses could be processed in four to six weeks to produce around 18 grams
of high-purity limonin glucoside, suitable for human studies. By industrial
standards, this type of productivity would be considered relatively
low-throughput, given that a dose of 500 mg/day/patient is required for
beverage supplementation studies. But, in the case of limonin or a related API
of similar molecular complexity, does partial or total chemical synthesis
offer a more scalable alternate supply chain approach to support downstream
clinical programs? In a forthcoming post, we will examine the first and only
reported chemical synthesis of limonin, disclosed in the summer of 2015 by
researchers at Tohoku University in Japan. We will then directly compare the
synthetic efficiency achieved by the world’s best organic chemists, using
state-of-the-art methods, with that of recovery from citrus processing waste
streams, in terms of practicality, cost and overall effort.
This comment has been removed by the author.
ReplyDelete